Brawn Biotech Limited (BOM:530207)
India · Delayed Price · Currency is INR 22.00
-0.25 (-1.12%)
At close: Jul 28, 2026
Brawn Biotech Market Cap
Brawn Biotech has a market cap or net worth of 66.01 million as of July 28, 2026. Its market cap has increased by 24.29% in one year.
Market Cap
66.01M
Enterprise Value
63.20M
Revenue
169.78M
Ranking
n/a
PE Ratio
6.75
Stock Price
22.00
ChartMarket Cap Chart
Since August 11, 2005, Brawn Biotech's market cap has increased from 23.22M to 66.01M, an increase of 184.24%. That is a compound annual growth rate of 5.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 66.01M | 2.28% |
| Dec 31, 2025 | 64.54M | 0.94% |
| Dec 31, 2024 | 63.94M | -2.69% |
| Dec 26, 2023 | 65.71M | 11.17% |
| Dec 30, 2022 | 59.11M | -13.79% |
| Dec 31, 2021 | 68.56M | -6.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rekvina Laboratories | 152.51M |
| Shamrock Industrial Company | 134.17M |
| Emmessar Biotech & Nutrition | 122.15M |
| Ortin Global | 116.77M |
| Beryl Drugs | 107.93M |
| Unjha Formulations | 106.68M |
| Vivanza Biosciences | 72.40M |
| Ganga Pharmaceuticals | 70.94M |